Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Pricing Reform In US: It’s Over For 2017

Jun 19 2017

• By Ramsey Baghdadi

White House

Related Content

Who Speaks For The White House On Drug Prices? Industry Better Hope It Is Not Donald Trump

Mar 14 2017

Breakthrough-Style Program For ANDAs Added To House User Fee Bill

May 19 2017

Generic Priority Review Expanded In Senate User Fee Bill

May 12 2017

340B Program Controls: House Committee Launches Investigation

Jun 08 2017

Can US FDA Save Pharma From Price Controls?

Jun 07 2017

Drug Pricing 'Deeper Dive' Planned By Senate Cmte. As Industry Avoids First Blood

Jun 14 2017

Related Companies

Vyera Pharmaceuticals, LLC

Additional Topics

United States Pricing Debate Pricing Strategies Trade Policy Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window